The Project

THERACAN (Exploiting molecular pathways of apoptotic cell death for the rational design of therapeutic strategies for colon cancer) is a 30 -month collaborative research programme, co-funded by the European Regional Development Fund of the EU and national funds- Greek Ministry of Education and Religious Affairs, Sport and Culture/GGET – ΕΥDΕ-ΕΤΑΚ, through the Operational Program Competitiveness and Entrepreneurship (OPC II), NSRF 2007-2013, Action “SYNERGASIA 2011” Project: THERA-CAN - No. 11ΣΥΝ_1_485.

 The 5 member consortium of THERACAN comprises expert scientists from Greece and is coordinated by the Molecular and Cellular Biology Laboratory Faculty of Medicine in Heraklion.

Project Details

Project:	ΤHERACAN
Duration:	30 months, commencing 17/12/2012
Contract no.:	THERA-CAN - No. 11ΣΥΝ_1_485
Total cost:	€ 1.195.000
European Regional Development Fund and National Funds:	€ 908.333,33

THERACAN: Exploiting molecular pathways of apoptotic cell death for the rational design of therapeutic strategies for colon cancer.